Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-12-049095
Filing Date
2012-08-31
Accepted
2012-08-31 06:02:09
Documents
5
Period of Report
2012-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v322729_6k.htm 6-K 811082
2 GRAPHIC cover.jpg GRAPHIC 89032
3 GRAPHIC image_001.jpg GRAPHIC 1700
4 GRAPHIC image_002.jpg GRAPHIC 2646
5 GRAPHIC image_003.jpg GRAPHIC 7869
  Complete submission text file 0001144204-12-049095.txt   952148
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 121067082
SIC: 2834 Pharmaceutical Preparations